The Pharmaceutical industry must prioritize sustainability. Jürgen Roos, Chief Scientific Officer (CSO) of Siegfried, explains opportunities and limits of sustainability...
There are only a few chemical and pharmaceutical companies that look back at a history of 150 years. Certainly, many companies claim such a long legacy, but if you only...
To boost supply of the injectable chemotherapy drug cisplatin – the US is facing a shortage of oncology treatments – the Food and Drug Administration (FDA) will...
To meet growing global demand, BASF is expanding output of global alkyl polyglucosides (APGs) at Bangpakong, Thailand, and Cincinnati, Ohio, USA. The group also produces...
LyondellBasell, Technip Energies and Chevron Phillips Chemical (CPChem) have signed a memorandum of understanding (MOU) to design, build and operate a demonstration unit...
Climate change, energy crisis, the call for a more environmentally compatible production method and socially responsible action do not stop at the pharmaceutical and...
The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...
The CDMO (contract development and manufacturing organizations) business has a bright future, of that Siegfried CEO Wolfgang Wienand is certain. The economic advantages...
Air Products is paying $1 billion to take over a natural gas-to-syngas processing facility in Uzbekistan. The industrial gases producer has signed a deal with the Uzbek...